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background: Statin use has been inconsistently observed to increase the risk of intracerebral haemorrhage (ICH). We aimed to examine the 
association between statin use and occurrence of ICH in Taiwanese statin users with varying risks for stroke.
methods: Patients who initiated statin therapy (atorvastatin, rosuvastatin, lovastatin, fluvastatin, pravastatin, and simvastatin) between 2005 
and 2009 were identified from Taiwan’s National Health Insurance research database. These statin users were classified into three categories: 1) 
those without history of cerebrovascular events, 2) those with previous ischemic stroke, and 3) those with previous hemorrhagic stroke. Information 
on different types of statins was collected from the outpatient pharmacy prescription database. Cumulative dosage and treatment duration were 
obtained. The outcome of interest was defined as a patient receiving a hospital diagnosis of ICH (ICD-9-CM codes 430, 431, 432). We applied a 
Cox regression model, adjusted for baseline disease risk score and time-varying statin use, to estimate the risk of ICH, using the lowest quartile of 
cumulative dosage and duration as a reference.
results: There were 1,139,058 statin initiators with an average follow-up of 3.3 years. Statin use was, in general, not associated with an excess 
risk of ICH in the three different stroke risk categories. One exception was an increased risk of ICH in low-risk patients who had had neither prior 
cerebrovascular events nor hypertension (HR 1.36, 95% CI: 1.11-1.67). On the other hand, a higher cumulative dosage or a longer treatment 
duration of low-efficacy statins (but not high-efficacy statins) was associated with a decreased risk of ICH in those patients with prior history of 
ischemic stroke (p < 0.05). 
conclusions: There was no obvious relationship between statin use and the risk of ICH. However, among low risk patients, intensive lipid-lowering 
therapy should be used with caution for fear of potentially increasing the risk of ICH.
